IM CANNABIS CORP. IMCNF overview

4:1 share consolidation to begin trading on February 12, 2021 NASDAQ Capital Market listing expected in Q1 2021 under ticker symbol IMCC TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / February 10, 2021 / IM Cannabis Corp. (the " Company " or " IMC ") (CSE:IMCC), a multi-country operator (" MCO ") in the medical cannabis sector with operations in Israel and Germany, is pleased to announce that, further to its press release dated December 17, 2020, it will be consolidating all of its issued and...

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / January 26, 2021 / IM Cannabis Corp. (the " Company " or " IMC ") (CSE:IMCC), a multi-country operator (" MCO ") in the medical cannabis sector with operations in Israel and Germany, is pleased to announce that the Company has received confirmation from The Depository Trust Company (" DTC ") that its common shares (" Common Shares ") are now eligible for electronic clearing and settlement through DTC in the United States. DTC eligibility is another...

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / January 12, 2021 / IM Cannabis Corp. (the " Company " or " IMC ") (CSE:IMCC), a multi-country operator (" MCO ") in the medical cannabis sector with operations in Israel and across Europe, is pleased to release a message from its Chief Executive Officer, Oren Shuster. Message to Shareholders Dear Shareholders, 2020 was an exceptional year for IMC and I am delighted to share that the Company is in a better position than ever to execute on its...

Combined Company will be a fully-integrated global leader in adult-use recreational and medical cannabis markets and the only MCO operating directly in Israel, the EU, and Canada, with forecast adjusted EBITDA profitability in 2021 IMC will leverage Trichome's premium indoor cultivation to meet growing demand for premium cannabis from IMC's established international distribution platform The acquisition of Trichome lays the foundation for IMC's North American growth strategy, with the Trichome...

Shareholders approved all motions, including a share consolidation required for the Company's NASDAQ Capital Market listing application Approval for listing on the NASDAQ expected in early 2021 TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / December 17, 2020 / IM Cannabis Corp. (the " Company " or " IMC ") (CSE:IMCC), a multi-country operator (" MCO ") in the medical cannabis sector with operations in Israel and across Europe, is pleased to announce that shareholders approved all of the motions...

Consolidated revenues increased to $5.9 million in Q3 2020, a 57% sequential increase, while realizing gross margin before fair value impacts of 57% The Company reached positive adjusted EBITDA of $0.3 million NASDAQ listing process progressing with expected listing early 2021 * Currency is in CAD$ unless specified otherwise TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / November 27, 2020 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator in the medical cannabis...

Legalization, if approved, is expected to result in an acceleration of growth in the Israeli recreational cannabis market as current black market consumers will gain legal access TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / November 16, 2020 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and across Europe, is pleased to announce that an Israeli government committee responsible for advancing...

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / October 8, 2020 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and across Europe, is pleased to announce that it has applied to list its common shares (the "Common Shares") on the NASDAQ Capital Market ("NASDAQ") under the trading symbol "IMCC". The Common Shares of the Company will continue to be listed on the Canadian Securities Exchange under the...